Literature DB >> 34125455

Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.

Chaogeng Zhu1, Guiyun He2, Qinqin Yin2, Lin Zeng3, Xiangli Ye4, Yongzhong Shi3, Wei Xu3.   

Abstract

The global coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to an unprecedented worldwide public health emergency. Despite the concerted efforts of the scientific field, by April 25, 2021, SARS-CoV-2 had spread to over 192 countries/regions, causing more than 146 million confirmed cases including 31 million deaths. For now, an established treatment for patients with COVID-19 remains unavailable. The key to tackling this pandemic is to understand the mechanisms underlying its infectivity and pathogenicity. As a predominant focus, the coronavirus spike (S) protein is the key determinant of host range, infectivity, and pathogenesis. Thereby comprehensive understanding of the sophisticated structure of SARS-CoV-2 S protein may provide insights into possible intervention strategies to fight this ongoing global pandemic. Herein, we summarize the current knowledge of the molecular structural and functional features of SARS-CoV-2 S protein as well as recent updates on the cell entry mechanism of the SARS-CoV-2, paving the way for exploring more structure-guided strategies against SARS-CoV-2.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; angiotensin-converting enzyme 2 (ACE2); coronavirus; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); spike Protein

Year:  2021        PMID: 34125455     DOI: 10.1002/jmv.27132

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

Review 1.  Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?

Authors:  Alfredo Parra-Lucares; Paula Segura; Verónica Rojas; Catalina Pumarino; Gustavo Saint-Pierre; Luis Toro
Journal:  Life (Basel)       Date:  2022-01-28

2.  From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?

Authors:  Matteo Pavan; Davide Bassani; Mattia Sturlese; Stefano Moro
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

3.  Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay.

Authors:  George B Sigal; Tanya Novak; Anu Mathew; Janet Chou; Yubo Zhang; Navaratnam Manjula; Predeepthi Bathala; Jessica Joe; Nikhil Padmanabhan; Daniel Romero; Gabriella Allegri-Machado; Jill Joerger; Laura L Loftis; Stephanie P Schwartz; Tracie C Walker; Julie C Fitzgerald; Keiko M Tarquinio; Matt S Zinter; Jennifer E Schuster; Natasha B Halasa; Melissa L Cullimore; Aline B Maddux; Mary A Staat; Katherine Irby; Heidi R Flori; Bria M Coates; Hillary Crandall; Shira J Gertz; Adrienne G Randolph; Nira R Pollock
Journal:  medRxiv       Date:  2021-12-09

4.  Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay.

Authors:  George B Sigal; Tanya Novak; Anu Mathew; Janet Chou; Yubo Zhang; Navaratnam Manjula; Pradeepthi Bathala; Jessica Joe; Nikhil Padmanabhan; Daniel Romero; Gabriella Allegri-Machado; Jill Joerger; Laura L Loftis; Stephanie P Schwartz; Tracie C Walker; Julie C Fitzgerald; Keiko M Tarquinio; Matt S Zinter; Jennifer E Schuster; Natasha B Halasa; Melissa L Cullimore; Aline B Maddux; Mary A Staat; Katherine Irby; Heidi R Flori; Bria M Coates; Hillary Crandall; Shira J Gertz; Adrienne G Randolph; Nira R Pollock
Journal:  Clin Infect Dis       Date:  2022-10-12       Impact factor: 20.999

5.  The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMINARTY vaccine (Pfizer/BioNTech).

Authors:  Jessica Andries; Wildriss Viranaicken; Colette Cordonin; Charline Herrscher; Cynthia Planesse; Bénédicte Roquebert; Marie Lagrange-Xelot; Chaker El-Kalamouni; Olivier Meilhac; Patrick Mavingui; David Couret; Gilles Gadea; Philippe Despres
Journal:  Sci Rep       Date:  2022-04-09       Impact factor: 4.996

6.  Impedimetric Detection Based on Label-Free Immunoassay Developed for Targeting Spike S1 Protein of SARS-CoV-2.

Authors:  Arzum Erdem; Huseyin Senturk; Esma Yildiz; Meltem Maral
Journal:  Diagnostics (Basel)       Date:  2022-08-17

Review 7.  Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths.

Authors:  Miguel A Ortega; Cielo García-Montero; Oscar Fraile-Martinez; Paolo Colet; Ardak Baizhaxynova; Kymbat Mukhtarova; Melchor Alvarez-Mon; Kaznagul Kanatova; Angel Asúnsolo; Antonio Sarría-Santamera
Journal:  J Pers Med       Date:  2022-06-18

Review 8.  Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19.

Authors:  Man Wang; Wenguang Chang; Lei Zhang; Yuan Zhang
Journal:  Int J Biol Sci       Date:  2022-09-21       Impact factor: 10.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.